Results 51 to 60 of about 13,834,757 (208)
ABSTRACT To better understand the comparative effectiveness of axicabtagene ciloleucel (axi‐cel) to historical standard of care (SoC) for the treatment of refractory diffused large B‐cell lymphoma (DLBCL) among patients of Asian descent, we conducted a matching‐adjusted indirect treatment comparison (MAIC) of the pivotal ZUMA‐1 trial (NCT02348216) and ...
Frederick L. Locke +6 more
wiley +1 more source
Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
Ligands for Stimulator of Interferon Genes (STING) receptor are under investigation as adjuvants in cancer therapy. Multiple effects have been described, including induction of immunogenic cell death and enhancement of CD8 T-cell mediated anti-tumor ...
Ruben Serrano +5 more
doaj +1 more source
Function and Spatial Organization of Tumor‐Invasive Human γδ T Cells—What Do We Know?
This review provides deeper insights into the localization of intra‐tumoral γδ T lymphocytes in solid tumors. Additionally, a pro‐ or anti‐tumoral influence of the tumor microenvironment and expression of checkpoint inhibitory molecules on γδ T cell functionality is described.
Kilian Wistuba‐Hamprecht +2 more
wiley +1 more source
UEG Week 2022 Poster Presentations
United European Gastroenterology Journal, Volume 10, Issue S8, Page 473-1092, October 2022.
wiley +1 more source
Gammadelta (γδ) T lymphocytes respond quickly upon antigen encounter to produce a cytokine response. In this study, we sought to understand how functions of γδ T cells are differentially regulated compared to αβ T cells.
Hsin-Yuan Cheng +7 more
doaj +1 more source
Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity
Human peripheral blood gammadelta T cells (Vgamma9(+) Vdelta2(+)) can be selectively expanded in vivo by the systemic administration of aminobisphosphonates without prior antigen priming.
Duwe S +5 more
core +5 more sources
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Adoptive cellular immunotherapy as a new paradigm to treat cancers is exemplified by the FDA approval of six chimeric antigen receptor-T cell therapies targeting hematological malignancies in recent years.
Chelsia Qiuxia Wang +3 more
doaj +1 more source
The γδT cell subset of peripheral lymphocytes exhibits potent cancer antigen recognition independent of classical peptide MHC complexes, making it an attractive candidate for allogeneic cancer adoptive immunotherapy.
Gabrielle M. Ferry +7 more
doaj +1 more source
SOX‐5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women
Objective Adaptive immunity mediates psoriatic disease pathogenesis. We aimed to identify novel psoriatic autoantigens and their phenotypic associations in deeply characterized patient cohorts. Methods Sera from psoriatic arthritis (PsA) patients were used for autoantibody discovery.
Ana‐Maria Orbai +9 more
wiley +1 more source
Potential of gamma/delta T cells for solid tumor immunotherapy
Gamma/delta T (γδ T)cells possess a unique mechanism for killing tumors, making them highly promising and distinguished among various cell therapies for tumor treatment.
Dantong Zhu +9 more
doaj +1 more source

